Monika K Chock, MD
Dermatology · Pleasanton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 24
- 5 carriers
- Office
- 1
- Since medical school
- 16 years
- Stanford University School of Medicine, 2010
Offices
1 location · Berman Skin Institute Medical Group Inc · 26 clinicians in this group
Looking this up.
Plans that list them
24 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chock’s office at (925) 416-1122 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
24 of 24 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A117774 · Current
Licensed to practise in California · since 2011 · expires 2027-03-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Dermatology - Dermatology
Original Medicare doctor bills
$21,975
Medicare paid this office $21,975 for 64 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 44 | $7,422 | $112 |
| Destruction of skin growth, 1-14 growths | 21 | $6,320 | $111 |
| Short return visit (20+ min) | 23 | $1,786 | $71 |
| Destruction of precancer skin growth, 1 growth | 16 | $1,345 | $46 |
| New patient visit (30+ min) | 12 | $1,077 | $90 |
See all 6 services
| Return visit (30+ min) | 44 | $7,422 | $112 |
| Destruction of skin growth, 1-14 growths | 21 | $6,320 | $111 |
| Short return visit (20+ min) | 23 | $1,786 | $71 |
| Destruction of precancer skin growth, 1 growth | 16 | $1,345 | $46 |
| New patient visit (30+ min) | 12 | $1,077 | $90 |
| Destruction of precancer skin growth, 2-14 growths | 15 | $726 | $7 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of skin lesions | 118 | More than 76% of doctors who do this |
| Removal or shaving of skin growth | 15 | More than 68% of doctors who do this |
| Skin biopsy | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | – | – | 168 | 78 | 107 | 108 |
| Destruction of skin growth, 1-14 growths | 15 | – | 58 | 65 | 48 | 57 |
| Destruction of precancer skin growth, 1 growth | 14 | – | 45 | 27 | 27 | 29 |
| Biopsy of related skin growth, first growth | – | – | 13 | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
64 Original Medicare patients in 2024. Average age 74 · Women 55% · Health risk score 0.92. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 69% · Diabetes 30% · Coronary heart disease 25% · Chronic kidney disease 22%.
The office billed $40,220, Medicare allowed $29,679 and paid $21,975; for 333 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 64 | 333 | 74 | 0.92 | $40,220 | $21,975 |
| 2023 | 65 | 332 | 73 | 0.71 | $41,088 | $20,047 |
| 2022 | 65 | 301 | 73 | 0.97 | $38,817 | $19,328 |
| 2021 | 131 | 493 | 72 | 0.98 | $52,455 | $28,477 |
| 2020 | 46 | 178 | 69 | 1.02 | $20,722 | $6,507 |
| 2019 | 68 | 250 | 69 | 1.55 | $56,048 | $13,385 |
| 2018 | 175 | 636 | 73 | 0.92 | $74,239 | $18,397 |
| 2017 | 286 | 1,218 | 73 | 0.82 | $149,653 | $54,519 |
| 2016 | 112 | 434 | 72 | 0.85 | $43,924 | $18,823 |
| 2015 | 21 | 58 | 73 | 0.71 | $6,347 | $2,740 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 36 | $6,253 | $103 |
| Destruction of skin growth, 1-14 growths | 26 | $4,660 | $97 |
| Short return visit (20+ min) | 22 | $1,620 | $62 |
| Destruction of precancer skin growth, 1 growth | 14 | $1,197 | $44 |
| New patient visit (30+ min) | 14 | $1,098 | $78 |
| Destruction of precancer skin growth, 2-14 growths | 14 | $724 | $7 |
2022: 6 services
| Destruction of skin growth, 1-14 growths | 28 | $6,415 | $99 |
| Return visit (30+ min) | 28 | $3,967 | $104 |
| Short return visit (20+ min) | 30 | $2,887 | $69 |
| Destruction of precancer skin growth, 1 growth | 18 | $1,061 | $39 |
| New patient visit (30+ min) | 11 | $951 | $86 |
| Destruction of precancer skin growth, 2-14 growths | 13 | $473 | $6 |
2021: 7 services
| Destruction of skin growth, 1-14 growths | 37 | $5,999 | $103 |
| Short return visit (20+ min) | 60 | $4,768 | $72 |
| New patient visit (30+ min) | 51 | $4,546 | $89 |
| Return visit (30+ min) | 29 | $3,455 | $115 |
| Destruction of precancer skin growth, 1 growth | 40 | $1,924 | $43 |
| Biopsy of related skin growth, first growth | 13 | $1,073 | $83 |
| Destruction of precancer skin growth, 2-14 growths | 32 | $1,051 | $6 |
2020: 2 services
| Short return visit (20+ min) | 19 | $1,929 | $57 |
| New patient visit (30+ min) | 13 | $830 | $64 |
2019: 7 services
| New patient visit (30+ min) | 21 | $1,804 | $86 |
| Destruction of skin growth, 1-14 growths | 11 | $1,395 | $93 |
| Short return visit (20+ min) | 15 | $1,176 | $59 |
| Short return visit (20+ min) | 14 | $786 | $36 |
| Destruction of precancer skin growth, 1 growth | 11 | $529 | $38 |
| New patient visit (15+ min) | 13 | $454 | $35 |
| Short return visit | 12 | $364 | $21 |
2018: 7 services
| Return visit (30+ min) | 83 | $4,857 | $57 |
| Destruction of precancer skin growth, 1 growth | 81 | $3,653 | $37 |
| Short return visit (20+ min) | 55 | $2,830 | $44 |
| Biopsy of single growth of skin and/or tissue | 21 | $1,580 | $72 |
| Destruction of skin growth, 1-14 growths | 13 | $1,089 | $84 |
| Destruction of precancer skin growth, 2-14 growths | 61 | $653 | $2 |
| Short return visit | 17 | $611 | $31 |
2017: 10 services
| Return visit (30+ min) | 152 | $12,094 | $77 |
| Short return visit (20+ min) | 138 | $9,597 | $51 |
| Destruction of precancer skin growth, 1 growth | 155 | $8,587 | $45 |
| Destruction of skin growth, 1-14 growths | 56 | $5,722 | $83 |
| Biopsy of single growth of skin and/or tissue | 59 | $5,163 | $78 |
| Destruction of precancer skin growth, 15 or more growths | 31 | $3,786 | $115 |
| New patient visit (45+ min) | 19 | $2,366 | $125 |
| New patient visit (30+ min) | 27 | $2,083 | $77 |
| Destruction of precancer skin growth, 2-14 growths | 101 | $1,804 | $4 |
| Short return visit | 33 | $1,205 | $33 |
2016: 7 services
| Short return visit (20+ min) | 75 | $4,977 | $59 |
| New patient visit (30+ min) | 34 | $2,973 | $87 |
| Destruction of precancer skin growth, 1 growth | 54 | $2,854 | $48 |
| Destruction of precancer skin growth, 15 or more growths | 16 | $1,995 | $125 |
| Biopsy of single growth of skin and/or tissue | 20 | $1,767 | $84 |
| Destruction of skin growth, 1-14 growths | 18 | $1,767 | $93 |
| Destruction of precancer skin growth, 2-14 growths | 38 | $847 | $5 |
Medicaid work
$384 in 2019
Medicaid paid $384 for 109 billed services this clinician did in 2019, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 30 | $227 |
| Short return visit (20+ min) | 13 | $64 |
| Short return visit | 53 | $52 |
| OFF/OP CONSLTJ NEW/EST SF 20 | 13 | $41 |
| 2019 | 109 | 4 | 19 | $384 |
| 2018 | 12 | 1 | 12 | $130 |
See the largest Medicaid services in earlier years
2018
| OFF/OP CONSLTJ NEW/EST SF 20 | 12 | $130 |
Drugs they prescribed that Part D paid
$84,195
Pharmacies billed $84,195 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 170) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
153 generic and 17 brand-name prescriptions · $84,195 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tacrolimus | 18 | $2,888 | $160 |
| Ciclopirox | 13 | $505 | $39 |
| Fluocinonide | 11 | $435 | $40 |
| Ketoconazole | 30 | $272 | $9 |
Year by year
| 2024 | 170 | 52 | 0% (0) | 10% | $84,195 |
| 2023 | 214 | 80 | 0% (0) | 14% | $62,807 |
| 2022 | 210 | 98 | 0% (0) | 7% | $18,952 |
| 2021 | 98 | 45 | 0% (0) | None | $6,304 |
| 2020 | 144 | 39 | 0% (0) | 24% | $29,466 |
| 2019 | 93 | 43 | 0% (0) | 18% | $9,449 |
| 2018 | 185 | 77 | 0% (0) | 21% | $25,977 |
| 2017 | 205 | 95 | 0% (0) | 13% | $22,508 |
| 2016 | 206 | 84 | 0% (0) | 10% | $12,308 |
| 2015 | 166 | 63 | 0% (0) | 14% | $16,401 |
| 2014 | 71 | 28 | 0% (0) | 25% | $12,471 |
| 2013 | 148 | 49 | 0% (0) | 20% | $41,153 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Tacrolimus | 17 | $3,511 | $207 |
| Clobetasol Propionate | 16 | $2,827 | $177 |
| Ketoconazole | 31 | $620 | $20 |
| Mupirocin | 32 | $329 | $10 |
| Doxycycline Hyclate | 14 | $326 | $23 |
| Triamcinolone Acetonide | 23 | $274 | $12 |
2022: 5 drugs
| Tacrolimus | 11 | $2,191 | $199 |
| Ketoconazole | 55 | $1,249 | $23 |
| Hydroxyzine | 11 | $350 | $32 |
| Triamcinolone Acetonide | 23 | $201 | $9 |
| Mupirocin | 21 | $141 | $7 |
2021: 2 drugs
| Ketoconazole | 14 | $358 | $26 |
| Triamcinolone Acetonide | 18 | $114 | $6 |
2020: 6 drugs
| Fluocinolone Acetonide | 11 | $971 | $88 |
| Clindamycin Phosphate | 11 | $592 | $54 |
| Mometasone Furoate | 11 | $291 | $26 |
| Ketoconazole | 13 | $179 | $14 |
| Triamcinolone Acetonide | 22 | $156 | $7 |
| Mupirocin | 13 | $97 | $7 |
2019: 2 drugs
| Fluocinonide | 14 | $864 | $62 |
| Mometasone Furoate | 23 | $722 | $31 |
2018: 5 drugs
| Jublia | 15 | $14,686 | $979 |
| Dapsone | 14 | $1,232 | $88 |
| Mometasone Furoate | 45 | $1,201 | $27 |
| Ketoconazole | 17 | $297 | $17 |
| Triamcinolone Acetonide | 11 | $97 | $9 |
2017: 4 drugs
| Fluocinonide | 15 | $1,053 | $70 |
| Mometasone Furoate | 39 | $820 | $21 |
| Ketoconazole | 17 | $571 | $34 |
| Triamcinolone Acetonide | 15 | $175 | $12 |
2016: 6 drugs
| Fluorouracil | 14 | $2,300 | $164 |
| Dapsone | 12 | $1,330 | $111 |
| Fluocinonide | 15 | $1,268 | $85 |
| Mometasone Furoate | 35 | $799 | $23 |
| Ketoconazole | 40 | $733 | $18 |
| Doxepin | 11 | $223 | $20 |
2015: 3 drugs
| Fluocinolone Acetonide | 12 | $1,861 | $155 |
| Fluocinonide | 15 | $1,463 | $98 |
| Mometasone Furoate | 18 | $340 | $19 |
2014: 2 drugs
| Fluocinonide | 23 | $1,724 | $75 |
| Triamcinolone Acetonide | 12 | $277 | $23 |
2013: 4 drugs
| Fluocinonide | 23 | $1,726 | $75 |
| Triamcinolone Acetonide | 32 | $873 | $27 |
| Doxepin | 11 | $187 | $17 |
| Hydrocortisone | 14 | $91 | $7 |
Money from drug and device companies
$1,532 in 2025
| 2025 | 12 | 90 | None | $1,532 |
| 2024 | 13 | 59 | None | $1,167 |
| 2023 | 13 | 36 | None | $677 |
| 2022 | 9 | 20 | None | $335 |
| 2021 | 4 | 6 | None | $134 |
| 2019 | 1 | 4 | None | $63 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| LEO Pharma | Adbry | $339 | 27 payments
|
| Lilly USA | Taltz | $267 | 12 payments
|
| Abbvie | Skyrizi | $199 | 11 payments
|
| Arcutis Biotherapeutics | Zoryve | $168 | 10 payments
|
| Incyte | Opzelura | $156 | 12 payments
|
| Organon | Vtama | $152 | 7 payments
|
See all 90 published payments
| Janssen Biotech | Education · 2025-12-22 | Tremfya | $72 |
| LEO Pharma | Meals · 2025-12-19 | Adbry | $17 |
| LEO Pharma | Meals · 2025-12-19 | Adbry | $17 |
| Abbvie | Meals · 2025-12-11 | Skyrizi | $32 |
| Ucb | Meals · 2025-12-05 | Bimzelx | $14 |
| LEO Pharma | Meals · 2025-12-02 | Adbry | $10 |
| LEO Pharma | Meals · 2025-12-02 | Adbry | $1 |
| LEO Pharma | Meals · 2025-12-02 | Adbry | $2 |
| LEO Pharma | Meals · 2025-12-02 | Adbry | $1 |
| LEO Pharma | Meals · 2025-12-02 | Adbry | $2 |
| LEO Pharma | Meals · 2025-12-02 | Adbry | $10 |
| LEO Pharma | Meals · 2025-11-21 | Adbry | $25 |
| Organon | Meals · 2025-11-20 | None | $27 |
| LEO Pharma | Meals · 2025-11-07 | Adbry | $21 |
| Organon | Meals · 2025-11-06 | None | $33 |
| Incyte | Meals · 2025-11-01 | Opzelura | $11 |
| Abbvie | Meals · 2025-10-31 | Rinvoq | $28 |
| Incyte | Meals · 2025-10-28 | Opzelura | $6 |
| Incyte | Meals · 2025-10-24 | Opzelura | $29 |
| Organon | Meals · 2025-10-23 | None | $9 |
| Pfizer | Meals · 2025-10-17 | Cibinqo | $19 |
| LEO Pharma | Meals · 2025-10-09 | Adbry | $14 |
| Lilly USA | Meals · 2025-10-02 | Taltz | $24 |
| Lilly USA | Meals · 2025-10-02 | Taltz | $1 |
| LEO Pharma | Meals · 2025-09-26 | Adbry | $23 |
| Organon | Meals · 2025-09-19 | None | $17 |
| Abbvie | Meals · 2025-09-18 | Rinvoq | $9 |
| Lilly USA | Meals · 2025-08-29 | Taltz | $29 |
| LEO Pharma | Meals · 2025-08-15 | Adbry | $19 |
| Organon | Meals · 2025-08-08 | None | $32 |
| Arcutis Biotherapeutics | Meals · 2025-08-07 | Zoryve | $24 |
| LEO Pharma | Meals · 2025-08-04 | Adbry | $12 |
| Ucb | Meals · 2025-08-02 | Bimzelx | $23 |
| Abbvie | Meals · 2025-07-31 | Rinvoq | $26 |
| Lilly USA | Meals · 2025-07-25 | Taltz | $27 |
| Arcutis Biotherapeutics | Meals · 2025-07-24 | Zoryve | $4 |
| Lilly USA | Meals · 2025-07-18 | Taltz | $27 |
| Abbvie | Meals · 2025-06-27 | Rinvoq | $26 |
| Ucb | Meals · 2025-06-27 | Bimzelx | $14 |
| Lilly USA | Meals · 2025-06-20 | Taltz | $30 |
| Incyte | Meals · 2025-06-17 | Opzelura | $8 |
| Lilly USA | Meals · 2025-06-13 | Taltz | $21 |
| Lilly USA | Meals · 2025-06-13 | Taltz | $4 |
| Arcutis Biotherapeutics | Meals · 2025-06-13 | Zoryve | $22 |
| Abbvie | Meals · 2025-05-30 | Rinvoq | $9 |
| LEO Pharma | Meals · 2025-05-30 | Adbry | $4 |
| LEO Pharma | Meals · 2025-05-30 | Adbry | $14 |
| LEO Pharma | Meals · 2025-05-16 | Adbry | $16 |
| Incyte | Meals · 2025-05-10 | Opzelura | $13 |
| Lilly USA | Meals · 2025-05-09 | Taltz | $24 |
| Incyte | Meals · 2025-05-09 | Opzelura | $2 |
| Ucb | Meals · 2025-05-02 | Bimzelx | $16 |
| Arcutis Biotherapeutics | Meals · 2025-05-02 | Zoryve | $29 |
| LEO Pharma | Meals · 2025-05-01 | Adbry | $14 |
| Sun Pharmaceutical Industries | Meals · 2025-04-25 | Winlevi | $20 |
| LEO Pharma | Meals · 2025-04-25 | Adbry | $20 |
| Lilly USA | Meals · 2025-04-24 | Taltz | $21 |
| Abbvie | Meals · 2025-04-18 | Skyrizi | $13 |
| Arcutis Biotherapeutics | Meals · 2025-04-17 | Zoryve | $20 |
| Incyte | Meals · 2025-04-16 | Opzelura | $11 |
| Incyte | Meals · 2025-04-11 | Opzelura | $18 |
| LEO Pharma | Meals · 2025-04-04 | Adbry | $7 |
| LEO Pharma | Meals · 2025-04-04 | Adbry | $15 |
| Genzyme | Meals · 2025-04-03 | Dupixent | $18 |
| LEO Pharma | Meals · 2025-03-27 | Adbry | $11 |
| Abbvie | Meals · 2025-03-21 | Skyrizi | $20 |
| Incyte | Meals · 2025-03-15 | Opzelura | $3 |
| Incyte | Meals · 2025-03-15 | Opzelura | $16 |
| Abbvie | Meals · 2025-03-14 | Skyrizi | $9 |
| Lilly USA | Meals · 2025-03-06 | Taltz | $26 |
| LEO Pharma | Meals · 2025-02-27 | Adbry | $10 |
| Janssen Biotech | Meals · 2025-02-21 | Tremfya | $19 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-21 | Sotyktu | $22 |
| LEO Pharma | Meals · 2025-02-21 | Adbry | $22 |
| Organon | Meals · 2025-02-20 | Vtama | $21 |
| Arcutis Biotherapeutics | Meals · 2025-02-20 | Zoryve | $18 |
| Incyte | Meals · 2025-02-14 | Opzelura | $17 |
| LEO Pharma | Meals · 2025-02-06 | Adbry | $10 |
| Lilly USA | Meals · 2025-01-31 | Taltz | $33 |
| Abbvie | Meals · 2025-01-31 | Skyrizi | $16 |
| Arcutis Biotherapeutics | Meals · 2025-01-28 | Zoryve | $13 |
| Incyte | Meals · 2025-01-24 | Opzelura | $21 |
| Pfizer | Education · 2025-01-24 | Cibinqo | $15 |
| Arcutis Biotherapeutics | Meals · 2025-01-24 | Zoryve | $19 |
| LEO Pharma | Meals · 2025-01-23 | Adbry | $8 |
| Organon | Meals · 2025-01-16 | Vtama | $14 |
| LEO Pharma | Meals · 2025-01-16 | Adbry | $13 |
| Arcutis Biotherapeutics | Meals · 2025-01-16 | Zoryve | $9 |
| Arcutis Biotherapeutics | Meals · 2025-01-14 | Zoryve | $10 |
| Abbvie | Meals · 2025-01-10 | Skyrizi | $10 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $1,167
| LEO Pharma | Adbry | $284 | 22 payments
|
| Abbvie | Skyrizi | $231 | 10 payments
|
| Sun Pharmaceutical Industries | Winlevi | $111 | 5 payments
|
| Genzyme | Dupixent | $104 | 3 payments
|
| Lilly USA | Taltz | $100 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $76 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $62 | 2 payments
|
| Galderma Laboratories L.P. | Aklief | $48 | 3 payments
|
| Dermavant Sciences | Vtama | $40 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $36 | 2 payments
|
| Arcutis Biotherapeutics | Zoryve | $31 | 1 payment
|
| Incyte | Opzelura | $30 | 2 payments
|
| Janssen Biotech | Tremfya | $14 | 1 payment
|
2023: $677
| Sun Pharmaceutical Industries | Winlevi | $156 | 11 payments
|
| Janssen Biotech | Tremfya | $143 | 8 payments
|
| LEO Pharma | Adbry | $72 | 4 payments
|
| Lilly USA | Taltz | $54 | 2 payments
|
| Smith+Nephew | Grafix | $53 | 1 payment
|
| Journey Medical | None | $37 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $34 | 1 payment
|
| Genzyme | Dupixent | $31 | 1 payment
|
| Pfizer | Cibinqo | $31 | 2 payments
|
| AbbVie | Skyrizi | $27 | 1 payment
|
| Almirall | Klisyri | $22 | 1 payment
|
| Dermavant Sciences | Vtama | $13 | 1 payment
|
| Janssen Scientific Affairs | Tremfya | $4 | 1 payment
|
2022: $335
| Abbvie | Skyrizi | $141 | 9 payments
|
| Regeneron Healthcare Solutions | Dupixent | $48 | 2 payments
|
| LEO Pharma | Adbry | $43 | 3 payments
|
| Janssen Biotech | Tremfya | $26 | 1 payment
|
| Sun Pharmaceutical Industries | Winlevi | $25 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $14 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $14 | 1 payment
|
| Incyte | Opzelura | $13 | 1 payment
|
| Genzyme | Dupixent | $12 | 1 payment
|
2021: $134
| Pfizer | Eucrisa | $73 | 3 payments
|
| Janssen Biotech | Remicade | $32 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $17 | 1 payment
|
| Genzyme | Dupixent | $11 | 1 payment
|
2019: $63
| Pfizer | Eucrisa | $63 | 4 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 88.4 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1356668735
- Licence
- CA A 117774California A117774: Current · expires 2027-03-31
- Trained
- Stanford University School of Medicine, 2010 · 16 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 101 Wilson Rd, Suite A, Monterey, CA, 93940
- NPI first listed
- 2010-04-26
- NPI last updated
- 2014-08-28
This is when the NPI record was last certified, not a medical board exam.